Pediatric Pulmonary (2014)
Attributed to:
Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: Supplement 38